- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03388827
Laminaria and Misoprostol Before Operative Hysteroscopy
December 6, 2018 updated by: IBRAHIM ABD ELGAFOR, Zagazig University
The Use of Laminaria Versus Laminaria Plus Misoprostol Before Operative Hysteroscopy in Nulliparous Women . A Double Blinded Randomized Trial.
Laminaria and Misoprostol before Operative Hysteroscopy
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The use of laminaria versus laminaria plus misoprostol was compared before operative hysteroscopy in nulliparous women to assess the efficacy of both methods in cervical dilatation.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ibrahim A EL sharkwy
- Phone Number: 00966554818576
- Email: ibrahimsharkwy@yahoo.com
Study Contact Backup
- Name: Mohamed L Elsayed
- Phone Number: 00201222442467
- Email: drmohamedlotfy@yahoo.com
Study Locations
-
-
-
Zagazig ,, Egypt
- Recruiting
- Zagazig University
-
Contact:
- Ibrahim A EL sharkwy, md
- Phone Number: 00966554818576
- Email: ibrahimsharkwy@yahoo.com
-
Contact:
- Mohamed L Elsayed, md
- Phone Number: 00201222442467
- Email: drmohamedlotfy@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria: nullipara
- need hystroscopic intervention
Exclusion Criteria: previous pregnancy
cervical lesion
contraindication to misoprostol
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Laminaria
Laminaria tent was introduced in the cervical canal
|
Laminaria tent was inserted for 12 hours before Hysteroscopy
|
Active Comparator: Laminaria plus Misoprostol
Laminaria and Misoprostol were introduced
|
Laminaria plus Misoprostol were inserted for 12 hours before Hysteroscopy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preoperative cervical width
Time Frame: 12 hours
|
cervical width in Hegar dilators number
|
12 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
adverse effects
Time Frame: 24 hours
|
adverse effects of the method used or hysteroscopy
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 20, 2017
Primary Completion (Anticipated)
December 1, 2018
Study Completion (Anticipated)
January 1, 2019
Study Registration Dates
First Submitted
December 25, 2017
First Submitted That Met QC Criteria
December 25, 2017
First Posted (Actual)
January 3, 2018
Study Record Updates
Last Update Posted (Actual)
December 7, 2018
Last Update Submitted That Met QC Criteria
December 6, 2018
Last Verified
December 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZUH- 9
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Spasm
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Hopital FochCompletedRadiotherapy Side Effect | Cervical Spasm | Botulinum ToxinFrance
-
Neurana Pharmaceuticals, Inc.CompletedBack Pain | Acute Pain | Back Muscle Spasm | Back Strain | Back Spasm Upper | Muscle SpasmUnited States
-
Phramongkutklao College of Medicine and HospitalUnknownRadial Artery SpasmThailand
-
ZetrOZ, Inc.Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingRadial Artery SpasmChina
-
Moorfields Eye Hospital NHS Foundation TrustCity, University of London; Merz PharmaceuticalsCompletedBlepharospasm | Hemi Facial SpasmUnited Kingdom
-
University of California, IrvineCompletedPelvic Floor Muscle SpasmUnited States
-
Stanford UniversityCompleted
-
Pr. Semir NouiraCompleted
Clinical Trials on Laminaria tent
-
Rush University Medical CenterCompletedTransmission, Patient-ProfessionalUnited States
-
University of PortsmouthUniversity College, London; University of Cambridge; Portsmouth Hospitals NHS... and other collaboratorsCompleted
-
Planned Parenthood of Greater New YorkSociety of Family PlanningCompletedSecond Trimester AbortionUnited States
-
University of California, San FranciscoCompleted
-
Boston UniversityTerminatedAbortion, InducedUnited States
-
University of ZurichSwiss Sportclinic BernActive, not recruitingPerfusion; Complications | Altitude HypoxiaSwitzerland
-
Cairo UniversityRecruiting
-
Wolfson Medical CenterCompletedInduced; Abortion, NonmedicalIsrael
-
Stanford UniversityNot yet recruitingRisk ReductionUnited States
-
Albany Medical CollegeCompleted